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Objective: This scoping review aims to provide an accessible summary of available
evidence on the efficacy of motivational interventions to increase adherence to
Continuous Positive Airway Pressure (CPAP) among patients with Obstructive Sleep
Apnea Syndrome (OSAS) and of their specific aspects and strategies by assessing
adherence measures.
Methods: A literature search was performed in PubMed, Scopus, Medline, PsycINFO,
and Web of Science databases using the concepts of “obstructive sleep apnea
syndrome,” “continuous positive airway pressure,” “motivational intervention,” and
“adherence.” Rigorous inclusion criteria and screening by at least two reviewers were
applied. Data were extracted to address the review aims and were presented as a
narrative synthesis.
Results: Search for databases produced 11 randomized controlled trials, all including
naïve CPAP users. Findings showed that motivational interventions were more effective
than usual care and educational programs in increasing adherence to CPAP, despite
results were not always maintained over time across studies.
Discussion: To our knowledge, this is the first scoping review of the literature aimed
to explore the characteristics and impact of motivational interventions to promote
adherence to CPAP in patients with OSAS.More research providing a detailed description
of motivational strategies, and testing of their association with positive treatment
outcomes via both direct and indirect measures are needed to increase awareness on
active mechanisms of change.
Keywords: sleep disorders, obstructive sleep apnea syndrome, continuous positive airway pressure, adherence,
motivational intervention
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INTRODUCTION
Obstructive Sleep Apnea Syndrome (OSAS) is a sleep-related
breathing disorder characterized by transient interruption of
ventilation during sleep caused by complete or partial occlusion
of the upper airway (McNicholas et al., 2007). Consequent oxygen
desaturation, increased inspiratory effort, sleep fragmentation,
and arousal from sleep (Lévy et al., 2015; Jennum et al., 2021) lead
to excessive daytime sleepiness, cardiovascular, and metabolic
diseases (Pépin et al., 2019; Visniauskas et al., 2021), cognitive
andmemory impairments (Alomri et al., 2021; Huang et al., 2021;
Legault et al., 2021), and mood disorders (Garbarino et al., 2020).
Continuous Positive Airway Pressure (CPAP) is the treatment
of choice for moderate to severe OSAS (Zhang et al., 2015; Chen
et al., 2021; Sugiyama et al., 2021). It involves the use of an airflow
generator which provides a constant stream of pressurized air to
splint open and maintain patency of the upper airways during
the inspiratory and expiratory phases of breathing. However, its
effectiveness is limited by poor acceptance and adherence (Bros
et al., 2020). The literature suggests that 8 to 15% of patients with
OSAS refuse CPAP treatment after the first night and that at least
50% of individuals discontinue its usage within 1 year from the
treatment beginning (Rotenberg et al., 2016; Borker et al., 2021;
Contal et al., 2021).
A dose-response relationship between CPAP adherence and
improvements in health and quality of life has been highlighted
in several studies, which show a substantial increase in memory,
functional status, and blood pressure (Gay et al., 2006; Giles et al.,
2006), as well as reduced rates of sleepiness and cardiovascular
mortality (Marin et al., 2005; Martínez-García et al., 2012; Dong
et al., 2013; Mashaqi and Gozal, 2020) among those who use the
device for a greater number of hours per night. However, what
remains unclear is the nightly duration of CPAP usage required
to normalize functioning (Lewis et al., 2004), which ranges from
a minimum of 4 h (Lewis et al., 2004; Richard et al., 2007) to
6–8 h per night (Zimmerman et al., 2006; Weaver et al., 2007)
across studies.
Specific barriers to treatment include skin irritation, dry
throat, nasal congestion, and mask leaks (Zozula and Rosen,
2001; Cayanan et al., 2019), but a reduction in side effects
offered by technical solutions (i.e., air humidifiers and different
types of devices) did not correlate with increased adherence
to CPAP, and quality of life in several investigations (Zozula
and Rosen, 2001; Weaver and Grunstein, 2008; Broström
et al., 2009; Sawyer et al., 2011). Adherence to CPAP use
might, therefore, depends on factors other than disease-specific
characteristics or technological advancements in the delivery of
positive airway pressure, including psychological, motivational,
and environmental aspects. These encompass characteristics of
negative affectivity and social inhibition associated with Type-
D (distressed) personality (Broström et al., 2007; Copur et al.,
2018), or symptoms of claustrophobia (Chasens et al., 2005),
while research findings are inconclusive on the association
between mood disorders, such as anxiety and depression, and
adherence to CPAP (Stepnowsky et al., 2002; Garbarino et al.,
2018; Yang et al., 2020; Scarpina et al., 2021). Additional factors
include coping styles with challenging situations (active vs.
passive), treatment expectations, and perceived self-efficacy (i.e.,
confidence in one’s own ability to carry out a particular behavior)
(Aloia et al., 2005; Olsen et al., 2008; Baron et al., 2011; Sawyer
et al., 2011; Mehrtash et al., 2019), together with social support
(Lewis et al., 2004; Xu et al., 2020), and marital satisfaction
(i.e., problems with the bed partner) (Batool-Anwar et al., 2017;
Luyster, 2017; Gentina et al., 2019).
Accordingly, findings from previous studies highlight that
interventions focused on enhancing knowledge about OSAS and
CPAP use, or on removing a potential barrier to device usage lead
only to partial improvements in treatment adherence (Aloia et al.,
2004; Minassian and Doran, 2020).
Indeed, behavioral change is a complex process involving
three specific constructs: (a) readiness to change, (b) perceived
importance of change, and (c) confidence in one’s ability to
change (Miller and Rollnick, 2002, 2013).
Several theoretically informed behavior change interventions
targeting the individuals’ motivation to change (Miller and
Rollnick, 1991, 2002; Kreman et al., 2006; Pietrabissa et al.,
2015) and self-efficacy (Miller et al., 1997; Pietrabissa et al.,
2013) to improve adherence to treatment recommendations have
been developed and successfully tested across chronic conditions
(Burke et al., 2003; Pietrabissa et al., 2012, 2017; Soderlund, 2018),
including pulmonary disease that requires the use of the CPAP
(Aloia et al., 2005; Weaver and Grunstein, 2008; Shannon et al.,
2017).
However, motivational interventions vary widely across
studies due to different theoretical backgrounds and employed
strategies, Moreover, adherence is operationalized and measured
differently across studies—thus limiting the conceptualization
of behavioral change interventions in clinical practice and the
generalization of research findings (Martin et al., 2005).
To overcome this gap, this study was conducted to
systematically review the research done in this area, as well
as to provide an accessible summary of available evidence on
motivational interventions to increase adherence to CPAP use
among patients with OSAS by answering the following research
questions: (1) Which are the characteristics of motivational
interventions to increase CPAP use/acceptance/adherence in
patients with OSAS? (2) Which motivational strategies are
specifically used to enhance adherence to CPAP in patients
with OSAS? (3) Which theoretical model underlines the
interventions? (4) Who provides the intervention? (5) How
adherence to CPAP is operationalized and measured, and what
are the reported effects (primary and secondary outcomes) of
motivational interventions in the short- and long-term?
METHODS
This scoping review employed the five-stage framework
as outlined by Arksey and O’Malley (2005) as follow: (1)
identifying the research question, (2) identifying relevant
studies, (3) selecting the studies, (4) charting the data (data
extraction), and (5) collating, summarizing, and reporting
the results. Furthermore, the PRISMA-ScR (Preferred
Reporting Items for Systematic reviews and Meta-Analyses
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extension for Scoping Reviews; Tricco et al., 2018) was used
(Supplementary Material 1).
Search Strategy
Searches were conducted in the PubMed, Scopus, Medline,
PsycINFO, and Web of Science databases from October 2020 to
March 2021.
The search strategies combined key terms and Medical Search
Headings (MESH) terms based on the patient problem (or
population), intervention, comparison, or control, and outcome
(PICO) framework as follows: (“OSAS” OR “Obstructive
Sleep Apnea Syndrome”) AND (“CPAP” OR “Continuous
Positive Airway Pressure”) AND (“Motivational intervention”
OR “Motivational treatment” OR “Motivational interviewing”)
AND (“Adherence” OR “Compliance” OR “CPAP use”) (Huang
et al., 2006). Boolean and truncation operators were used to
systematically combine searched terms and to list documents
containing variations on search terms, respectively. The search
syntax was modified as appropriate for each database.
Inclusion and Exclusion Criteria
Only original articles that (1) employed randomized controlled
trials (RCTs), non-randomized trials, or non-controlled trials
study designs, (2) were published in English, and (3) examined
the impact of motivational interventions on adherence (primary
outcome) to CPAP use in adult (4) with a primary diagnosis
of OSAS (5) were included. Records were excluded if they (1)
considered only biomedical outcome variables, (2) were review
articles, single-case studies, qualitative studies, mixed-method
studies, protocol studies, or workplace interventions.
Unpublished works were not considered. No restrictions were
set for the date of publication.
Study Selection
Following the search and exclusion of duplicates, two reviewers
(authors 1 and 2) independently assessed the eligibility
of the articles first on the title and the abstract, and
the full-text according to the inclusion criteria. Author 3
resolved disagreements. The reference lists of all selected
articles and relevant systematic reviews (Weaver, 2019) were
manually screened to identify any further references for possible
inclusion—but none was found.
RESULTS
Study Selection
A search of electronic databases identified 115 reports, of which
98 were excluded based on information from the title and
abstract. The remaining 17 articles were evaluated for inclusion
by reviewing their full text and resulted in the exclusion of 6
records for the following reasons: (1) focused on motivational
App development and testing (n = 1; Alismail and Olfman,
2020), (2) aimed at validating a screening questionnaire (n = 1;
Sawyer et al., 2014), (3) was a review (n = 1; Weaver, 2019) or
(4) a protocol study (n = 1; Williams et al., 2014), (5) OSAS was
not reported as the primary diagnosis (n = 1; Whittington et al.,
2020) and (6) employed a mixed-method study design (n = 1;
Broström et al., 2013). Eleven records finally were included in this
review (Roecklein et al., 2010; Sparrow et al., 2010; Olsen et al.,
2012; Aloia et al., 2013; Lai et al., 2014; Lo Bue et al., 2014; Dantas
et al., 2015; Bakker et al., 2016; Jean-Louis et al., 2017; Pengo et al.,
2018; Rudilla et al., 2021).
The flowchart presented in Figure 1 provides step-by-step
details of the study selection.
Study Characteristics
Details of the 11 included papers are provided in Table 1.
The selected articles were published from 2010 (Roecklein
et al., 2010; Sparrow et al., 2010) to 2021 (Rudilla et al., 2021),
and were conducted in the USA (Roecklein et al., 2010; Sparrow
et al., 2010; Aloia et al., 2013; Bakker et al., 2016; Jean-Louis et al.,
2017; n = 5), China (n = 1; Lai et al., 2014), Australia (n = 1;
Olsen et al., 2012), UK (n = 1; Pengo et al., 2018), Portugal (n =
1; Dantas et al., 2015), Spain (n= 1; Rudilla et al., 2021) and Italy
(n = 1; Lo Bue et al., 2014). All studies employed a randomized
parallel-group trial design.
Description of Participants
Selected contributions included a total of 1472 adult participants
of both genders (age range: 34-75; mean age = 54.66 years)
with a diagnosis of OSAS at their first use of a recognized sleep
diagnostic tool with an Oxygen Desaturation Index (ODI) of≥ 5
per hour or an Apnea-Hypopnea Index (AHI) ≥ 5 per hour.
Description of Intervention
The main characteristics of the interventions are reported in
Supplementary Material 2 using the CONsolidated Standards
of Reporting Trials 2010 (Consort10) checklist (Schulz et al.,
2010) and Supplementary Material 3 using the Template for
Intervention Description and Replication (TIDieR) checklist
(Hoffmann et al., 2014). Figure 2 showed substantial differences
in reporting frequency occurred between TIDieR items in each of
the 11 trial reports.
Intervention Group
Intervention groups were based on the principles and techniques
of Motivational Interviewing (MI) (Olsen et al., 2012; Dantas
et al., 2015; Rudilla et al., 2021) and Motivational Enhancement
Therapy (MET) (Roecklein et al., 2010; Sparrow et al., 2010; Aloia
et al., 2013; Lai et al., 2014; Lo Bue et al., 2014; Bakker et al., 2016),
which combinesMIwith personalized assessments, feedback, and
change plans (Miller, 1992).
The number of intervention sessions ranged from one
(Roecklein et al., 2010; Lai et al., 2014; Lo Bue et al., 2014; Dantas
et al., 2015) to 16 (Sparrow et al., 2010), and the length of each
session varied from 2 (Pengo et al., 2018) to 90min (Rudilla et al.,
2021).
In all the selected studies, the treatment consisted of providing
OSAS-related information, addressing treatment expectations,
and ambivalence toward the use of the CPAP, as well as
in defining goals and motivating treatment adherence. The
individual’s understanding of the health risks associated with
untreated OSAS and the extent to which they believed that
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FIGURE 1 | Flow chart diagram.
consistent CPAP use would lead to symptoms improvement were
also discussed during treatment.
However, only 4 out of 11 contributions detailed the
motivational strategies employed in the intervention (Olsen et al.,
2012; Aloia et al., 2013; Jean-Louis et al., 2017; Rudilla et al.,
2021).
In the study by Aloia et al. (2013) and Jean-Louis et al. (2017),
the practitioners first discussed with the patients what they
already knew or were interested in learning about the impact that
sleep apneas and the use of the CPAP have on health and asked
the patients for permission to provide information. Information
was given in a neutral, non-judgmental fashion to elicit the
patient’s interpretation (the elicit-provide-elicit technique). The
goal-setting technique was then used to identify and set realistic
goals that align with the patients’ values (Aloia et al., 2013;
Jean-Louis et al., 2017). Moreover, in the study by Jean-Louis
et al. (2017), coaching and role-playing techniques were applied.
In the final phase of the intervention, the practitioners also
complimented the patients for the achieved results and offered
further education on the benefits of CPAP therapy in case
resistance to change was encounter.
Instead, in the study by Olsen et al. (2012), the first
session focused on increasing readiness to change by exploring
the patients’ motivation to treatment, assessing discrepancies






































TABLE 1 | Characteristics of the included studies.
Author,
year
































































































time for all three groups.
Among moderate users (≥2
but <6 h/night) in the first
week, average adherence at
T12 in the IG was
significantly higher
(M = 4.12 h/night,
SE = 0.42) than the average
adherence in the other two
control groups (TAU:
M = 2.46 h/night,
SE = 0.40; ED: M = 3.21
h/night, SE = 0.40;
p = 0.002).
For self-efficacy at T12 IG had
the highest mean confidence
score for moderate PAP users
and ED had the highest mean
confidence score for high users,
but there were no significant
group differences.
TAU: T0 = 20.96 (2.88);
T3 = 20.61 (4.49); T6 = 21.00
(5.06); T12 = 19.83 (6.29)
ED: T0: 21.11 (3.21); T3 = 21.05
(4.50); T6 = 21.04 (5.03);
T12 = 20.98 (5.19)
IG: T0 = 20.63 (3.26);
T3 = 22.48 (3.08); T620.96
(4.23); T12 = 21.25 (4.84)
For decisional balance the
moderate user group (≥ 2 but <
6 h/night) of IG demonstrated a
higher index score at T12 when
compared to the average of
other two groups for moderate
users (p = 0.04).
TAU: T0 = 47.11 (6.02);
T3 = 45.51 (7.67); T6 = 45.51
(7.90); T12 = 45.08 (10.55)
ED: T0 = 46.32 (5.70);
T3 = 46.33 (7.69); T6 = 44.66
(9.14); T12 = 45.76 (8.38)
IG: T0 = 45.28 (6.94);
T3 = 46.13 (6.23); T6 = 45.91












































Sleep duration TAU: 16
(38%)
IG: 15(36%)
At T6, average nightly
adherence was 99.0
min/night higher in IG
compared with TAU
(p = 0.003). At T12 a
consistent difference in
adherence between arms of
97 min/night (p = 0.006)
favoring IG.
There were no significant
differences in sleep duration,































































ED: 1 The IG presented higher
adherence to
CPAP—percentage of days
of use >4 h (89.8%
p = 0.013), mean effective
use per effective day (6.2;
p = 0.000) at T2, compared
with TAU and IN groups.
IG showed lower AHI (2.7;
p = 0.019) at T2 when compared
with the other two groups. For
conviction, no differences were
detected. Confidence was higher
in the IG group at T2 than at T1
(p = 0.000). The ESS presented
a significant reduction
(p = 0.000) in the IG and the IN
(p = 0.008) but was higher in the

























































































TABLE 1 | Continued
Author,
year






































































































































The IG had better CPAP use
(higher daily CPAP usage by
2 h/d) [Cohen d = 1.33, p <
0.001], a four-fold increase
in the number using CPAP
for ≥70% of days with ≥4
h/d (p < 0.001) compared
with TAU at T3.
TAU: T1w = 2.9 (2.5);
T1 = 2.6 (2.3); T3 = 2.4
(2.3)
IG: T1w = 5.5 (1.8);
T1 = 4.8 (1.6); T3 = 4.4 (1.8)
No between-group differences
on Risk perception, Outcome
expectancies and in any score of
the three health-related
quality-of-life scales. The IG had
greater improvements in ESS by
2.2 units (p < 0.001) and














































During the first month,
intervention group patients
showed a higher number of
nights with a device use
≥4 h. Average treatment
adherence in the T1 (days of
therapy with at least 4 h per
night on the total number of
days from device delivery)
was 77.5% in IG and 55.7%
in TAU (p = 0.022). No
significant differences in
other follow-up points.
Both in the IG and TAU, ESS
was lower at the 3rd, 6th, and
12th month than at baseline with
no significant differences


































































NR Adherence declined over
time in the two groups. The
number of hours of CPAP
use per night in the IG at T1,
T2, and T3 was significantly
higher compared with TAU
(p < 0.005). No significant
between-group difference at
T12.
TAU: T1 = 3.25 (2.83);
T2 = 3.22 (2.76); T3 = 3.16
(2.69); T12 = 3.00 (3.18)
IG: T1= 4.85 (2.55);
T2 = 4.73 (2.62); T3 = 4.63
(2.69); T12 = 4.21 (3.25)
Significantly more
participants in the IG
For ESS, no between-group
differences, but the main effect
for time emerged (TI–T3 mean
ESS: 10.04 vs. 6.73, p < 0.01;
T2–T3 mean ESS: 8.90 vs. 6.73,
p < 0.01). For SMSA, IG showed
greater self-efficacy than TAU
but not significantly (3.42 vs.
3.11). A significant main effect for
time is reported for the reduction
in risk perception between T1
and T3 (p < 0.05) in all patients.
A significant main effect for time
is reported for better
health-related quality of life from
T1 to T2, from T2 to T3, and

























































































TABLE 1 | Continued
Author,
year






























commenced on CPAP at T3
(6% rejection rate)
compared to ED (28%
rejection rate) (p = 0.004). At
T12, the difference between
CPAP commencement in
the IG (4% rejection rate)
compared to the ED (26%
rejection rate) was still
significant, (p = 0.002).
The STTS-R was not correlated
























































usage after 2 weeks (total
use 53.7 ± 31.4 h)
compared to the IG(–) (35.6
± 27.4) and TAU (40.8 ±
33.5 h, p < 0.05); however,
no differences were seen at
6 weeks.
ESS improved in all patients
(baseline 11.0 (6.0) vs. ESS at 2
weeks 9.2 (5.9) points, p <
0.0001) with no significant
differences among groups. There


























































There was no difference in
objective average daily use
or total hours
between-group at T2w and
T3, but in both groups, the
daily use of CPAP
decreased. Individuals in the
IG with self-report measure
reported using CPAP longer
than controls in both time
points, but at T3 the
adherence-reported level is
significantly higher in IG
[F (1,22) = 7.13, p < 0.05]
TAU: T2w = 7.11 (8.45);
T3 = 66.43 (32.07)
IG: T2w = 11.26 (7.89);
T3 = 93.75 (15.83)
Groups did not differ in rates of
CPAP side effects, daytime
sleepiness, or symptoms
between time points. There was
a main effect of time on
symptoms due to the expected
decrease in symptoms over time
[F (1,25) = 15.49, p < 0.01].
Readiness at T2w predicted total
therapy hours at T3
(β = −207.97, Seβ = 94.60, p <
0.05), readiness improved
significantly over time



























































were obtained in favor of IG
(p < 0.01), with a mean
difference of 1.60 h (95% CI,
0.60–2.61).
CEPCA was significantly higher
in IG at T3 with a mean
difference of 4.61 (95% CI, 3.49
to 5.72) (p < 0.001). VAWBS-A
was significantly higher in IG at
T3 (p < 0.001.). No statistically
significant differences were
observed for ESS when
comparing the before-after
change between the treatment
arms at T3, but there were
statistically significant differences
found when comparing the


























































































TABLE 1 | Continued
Author,
year




































































































The intervention had a
significant effect on CPAP
adherence: median
observed CPAP use in
patients in IG was
approximately 1 h/night
higher than in subjects of
TAU at 6 months (p = 0.006)
and 2 h/night higher at 12
months (p = 0.004)
CPAP adherence was
significantly associated with a
greater reduction in sleep apnea
symptoms and depressive
symptoms and a greater
improvement in functional status.
At T6 and T12 IG scored
significantly higher than TAU on
self-efficacy and decisional
balance
TAU(self-efficacy): T6 = 4.2,
3.0–4.8; T12 = 4.2, 3.0–5.0
IG(self-efficacy): T6 =4.4,
3.8–5.0; T12 = 4.6, 3.6–5.0
TAU(decisional balance):
T6 = −3.0, −10.5–4.0;
T12 = −2.0, −11.0–4.0
IG(decisional balance): T6 = 1.2,
−6.0–7.0; T12 = 0.0, −6.0–6.0
AHI, Apnea-Hypopnea index; AU, Australia; CEPCA, Questionnaire of Evaluation of Perceived Competence in Adherence to CPAP in OSAS; CES-D, the Center for Epidemiological Studies Depression; CH, China; CSAQLI, Calgary
Sleep Apnea Quality of Life Index; ESS, Epworth Sleepiness Scale; FOSQ, Functional Outcomes of Sleep Questionnaire; IT, Italy; PT, Portugal; PVT, Psychomotor Vigilance Task; SEMSA, Self-Efficacy Measures Of Sleep Apnea; SEQ,
The Side Effects Questionnaire; SF-36, Short Form-36 Health Survey Questionnaire; SMSA, Self-Efficacy Measure for Sleep Apnea; SP, Spain; SSC, Sleep Symptoms Checklist; STTS-R, The Satisfaction with Therapy and Therapist
Scale–Revised; UK, The United Kingdom; US, The United States; VAS, Visual Analog Scale; VAWBS-A, Visual Analogical Well-Being Scale for Apnoea.
*Patient-Reported Outcomes in bold; **Psychological data measurements in bold. Where not otherwise specified, times are expressed in months.
†
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FIGURE 2 | Proportion of TIDieR items not/partly or fully included in each of the 11 trial reports.
between their ideal and current behavior (decisional balance
technique), and eliciting self-motivational statements (change
talk). The importance of CPAP use was also discussed, and
emphasis was placed on the patients’ autonomy. The second
session was aimed at strengthening the patient’s commitment
to change, summarizing the pros and cons of the use of CPAP,
and setting realistic goals to achieve. Following, the patient’s
improvements were reviewed and reinforced, while key barriers
to CPAP use were identified and addressed. In the study by
Rudilla et al. (2021), motivational strategies were adapted to
the patient’s stage of change (Prochaska and DiClemente, 1983).
When in the pre-contemplation phase, information was provided
while dealing with resistance to change and supporting the
patients’ self-efficacy. In the contemplation phase, the pros
and cons of change were discussed to support goal setting.
In the determination phase, emphasis was made on setting
a change plan. In the maintenance phase, strategies to deal
with risk situations were provided. In case of relapses, the
patients were helped to understand their reason causes, while
confidence in their ability to make behavioral changes and
related action plans were further supported. Further, in the
study by Pengo et al. (2018), health-related information was
offered in terms of either risk or benefits framed via positive or
negative message.
Notably, only 4 out of 11 studies (Aloia et al., 2013; Dantas
et al., 2015; Jean-Louis et al., 2017; Rudilla et al., 2021) tailored
motivational intervention strategies according to the patient’s
initial degree of readiness to change and confidence in their
ability to succeed.
In four studies the treatment was conducted by a
motivational-trained-nurse (Olsen et al., 2012; Aloia et al.,
2013; Lai et al., 2014; Rudilla et al., 2021), in two studies by
a sleep doctor/sleep technician (Lo Bue et al., 2014; Pengo
et al., 2018), and in one record by a psychologist (Bakker
et al., 2016) and by a trained health educator (Jean-Louis et al.,
2017), respectively. A multidisciplinary intervention involving a
pulmonologist, psychologist, and physiotherapist was employed
in one study (Dantas et al., 2015), while Sparrow et al. (2010)
implemented the intervention with the use of an automated
telephone-linked communication system. Only Roecklein et al.
(2010) did not mention who conducted the intervention.
The treatment was conducted through regular in-person
meetings in four studies (Roecklein et al., 2010; Olsen et al.,
2012; Aloia et al., 2013; Rudilla et al., 2021), while in five
contributions (Sparrow et al., 2010; Lo Bue et al., 2014; Jean-Louis
et al., 2017) motivational interventions were entirely provided
via remote interactions, and in three studies the interventions
began in-person followed by telephone-based follow-ups sessions
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(Lai et al., 2014; Bakker et al., 2016; Pengo et al., 2018) or the use
of an App motivating and assisting the use of the CPAP.
Ad hoc video education offering real-life experiences with the
CPAP was also used in 2 out of 11 studies in addition to the
motivational intervention (Lai et al., 2014; Bakker et al., 2016).
Moreover, a single motivational group-format intervention
with 20 participants was employed in one contribution
(Dantas et al., 2015).
The theoretical background of the intervention was reported
in 5 out of 11 studies (Roecklein et al., 2010; Sparrow et al.,
2010; Olsen et al., 2012; Aloia et al., 2013; Rudilla et al., 2021).
Aloia et al. (2013) and Roecklein et al. (2010) referred both to
the Social Cognitive Theory (SCT; Bandura et al., 1999) and
the Transtheoretical Model of Change (TTM; Prochaska and
DiClemente, 1983). In Rudilla et al. (2021) and Sparrow et al.
(2010), the interventions were respectively based on the TTM
and SCT, while in Olsen et al. (2012) on the Health Belief Model
(HBM; Becker, 1974).
Control Group
Six studies compared the intervention group with a standard
care condition only (treatment as usual; TAU) (Roecklein et al.,
2010; Lai et al., 2014; Lo Bue et al., 2014; Bakker et al.,
2016; Pengo et al., 2018; Rudilla et al., 2021). Educational
sessions focused on increasing awareness on the benefits of
a healthy lifestyle and of the use of the CPAP were, instead,
used as controls in two contributions (Sparrow et al., 2010;
Olsen et al., 2012; Aloia et al., 2013; Jean-Louis et al., 2017),
while two records included both TAU and educational controls
(Aloia et al., 2013; Dantas et al., 2015).
Effects of the Intervention Across
Time-Points
Primary Outcomes
Study duration ranged from 2 weeks (Pengo et al., 2018) to 12
months (Sparrow et al., 2010; Olsen et al., 2012; Aloia et al.,
2013; Lo Bue et al., 2014; Bakker et al., 2016). In one study, the
intervention had a duration of 2 months (Dantas et al., 2015),
3 months (Roecklein et al., 2010; Lai et al., 2014; Rudilla et al.,
2021), or 6 months (Jean-Louis et al., 2017), respectively.
In 10 studies data related to hourly CPAP usage were used
to measure adherence to treatment as a primary outcome
(Roecklein et al., 2010; Sparrow et al., 2010; Olsen et al., 2012;
Aloia et al., 2013; Lai et al., 2014; Lo Bue et al., 2014; Dantas et al.,
2015; Bakker et al., 2016; Pengo et al., 2018; Rudilla et al., 2021),
and in 1 study patients were directly asked if they were following
the indications (Jean-Louis et al., 2017). Only Roecklein et al.
(2010) used both objective (CPAP usage data) and subjective
(self-report ad-hoc questionnaire) measures of adherence.
Nine out of 11 studies showed that motivational interventions
were effective in increasing the average hours of CPAP use
(Sparrow et al., 2010; Olsen et al., 2012; Aloia et al., 2013; Lai
et al., 2014; Lo Bue et al., 2014; Dantas et al., 2015; Bakker
et al., 2016; Pengo et al., 2018; Rudilla et al., 2021). In particular,
significantly higher CPAP adherence was found after 2 weeks
(Pengo et al., 2018) and 1 month (Lo Bue et al., 2014) from CPAP
titration among participants in the motivational group compared
with those receiving usual care, despite in Lo Bue et al. (2014)
results were not maintained over time. Similarly, in the study
by Dantas et al. (2015), patients assigned to the experimental
condition presented significantly higher adherence to CPAP
after 2-month from CPAP titration than those in the TAU and
educational controls. Moreover, three studies assessed adherence
to CPAP after 3 months from the beginning of the treatment
and showed that motivational interventions were significantly
more effective than TAU (Olsen et al., 2012; Lai et al., 2014;
Rudilla et al., 2021) and educational controls (Olsen et al., 2012),
respectively. Participants in the motivational interventions also
revealed a significantly higher CPAP adherence compared with
TAU (Bakker et al., 2016) and the educational control group
(Sparrow et al., 2010) at 6- and 12-month follow-ups in 2 records
and another study showed significant between-group differences
at 12 months in favor of those participants in the motivational
group who displayed moderate levels of adherence during their
first week of CPAP use compared to both TAU and educational
controls (Aloia et al., 2013). Instead, no significant between-
group differences were found by Jean-Louis et al. (2017) and by
Roecklein et al. (2010)—but a greater likelihood of adhering to
CPAP was detected among patients receiving the motivational
intervention compared to those participating in the educational
group. Specifically, in Roecklein et al. (2010), significantly higher
self-reported adherence was reported in the intervention group
at 2-week and 3-month follow-ups.
The figures below show the mean daily usage of CPAP
(h/night) across conditions at different time-points as reported
in the selected studies (Figure 3) and provide a summary of
motivational interventions by type of intervention format that
has been shown effective in increasing adherence to CPAP in
the short- and long-term, according to Webb et al.’ taxonomy
(Webb et al., 2010) (Figure 4). The studies by Jean-Louis et al.
(2017) and by Roecklein et al. (2010) were, therefore, excluded
despite showing that patients in the intervention group had a
greater likelihood of adhering to recommended CPAP compared
with the educational group, and indicated significantly higher—
but self-reported—adherence to CPAP thanTAU and educational
controls, respectively.
Secondary Outcomes
Seven out of the 11 selected studies made use of the Epworth
Sleepiness Scale (ESS) to report the presence and intensity of
daytime sleepiness (Roecklein et al., 2010; Olsen et al., 2012; Lai
et al., 2014; Lo Bue et al., 2014; Dantas et al., 2015; Pengo et al.,
2018; Rudilla et al., 2021).
In one study, after 3 months among participants in the
motivational group compared with TAU. the ESS scores
decreased significantly in the intervention group compared with
TAU and educational controls at 1 and 2 months after CPAP
titration (Dantas et al., 2015), while in another record (Lai et al.,
2014) daytime sleepiness reduced significantly.
Instead, five studies failed to detect significant between-group
differences in the ESS scores across conditions (Roecklein et al.,
2010; Olsen et al., 2012; Lo Bue et al., 2014; Pengo et al., 2018;
Rudilla et al., 2021), but an overall improvement of ESS among
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FIGURE 3 | Mean daily usage of CPAP (hours/night) across conditions at different time-points.
FIGURE 4 | Efficacy of motivational interventions by type of intervention format. 1, Pengo et al., 2018; 2, Lo Bue et al., 2014; 3, Dantas et al., 2015; 4, Lai et al., 2014;
5, Olsen et al., 2012; 6, Rudilla et al., 2021; 7, Bakker et al., 2016; 8, Sparrow et al., 2010; 9, Aloia et al., 2013.
all the respondents was found in three studies (Olsen et al., 2012;
Lo Bue et al., 2014; Pengo et al., 2018).
Moreover, one contribution showed over time an AHI
improvement across conditions, and significantly lower AHI
scores were registered after 2 months from CPAP titration in
the motivational group compared with the educational and TAU
controls (Dantas et al., 2015).
Two records (Olsen et al., 2012; Lai et al., 2014) also assessed
OSAS risk perception. Although no significant between-group
difference was found, it reduced significantly between 1 and 3-
month follow-ups in one contribution (Olsen et al., 2012), while
no significant improvement was shown by Lai et al. (2014).
Self-efficacy was assessed in six studies (Sparrow et al., 2010;
Olsen et al., 2012; Aloia et al., 2013; Lai et al., 2014; Dantas et al.,
2015; Rudilla et al., 2021) using: self-statements investigating the
participants’ confidence in their ability to follow the treatment
recommendations (Sparrow et al., 2010; Aloia et al., 2013), the
Self-efficacy Measure for Sleep Apnea (SMSA) (Olsen et al., 2012;
Lai et al., 2014) the Questionnaire of Evaluation of Perceived
Competence in Adherence to CPAP in OSA (Rudilla et al., 2021)
or a Visual Analog Scale (VAS) (Dantas et al., 2015).
No between-group differences were detected with the first
measure. However, self-efficacy levels decreased over time in
the control conditions, while improving among participants in
the motivational intervention in one study (Aloia et al., 2013).
Moreover, Sparrow et al. (2010) observed a significant increase
in self-efficacy at 6- and 12-month follow-ups in favor of the
motivational group compared with TAU.
Significantly higher rates of self-efficacy were also found
by Dantas et al. (2015) at 2-month follow-up among patients
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assigned to the motivational intervention compared with those
receiving education. Self-efficacy increased in the motivational
group and decreased in the control conditions.
Instead, even though higher SMSA scores were detected at
3-month follow-up in the motivational group compared with
TAU, statistical between-group differences were found only in
one contribution (Lai et al., 2014). These results were parallel
to those by Rudilla et al. (2021), which showed that competence
increased significantly at 3-month follow-up in the motivational
group compared with TAU (Rudilla et al., 2021).
The construct of health-related quality was measured with
the Functional Outcomes of Sleep Questionnaire (FOSC) in two
contributions (Olsen et al., 2012; Lai et al., 2014). No between-
group differences were observed in both studies, but in Olsen
et al. (2012), increased scores were observed at 3-month follow-
up across conditions. Instead, in the study by Rudilla et al. (2021)
patients assigned to the motivational intervention showed better
quality of life measured by the Visual AnalogicalWell-being Scale
for apnoea than TAU after 3 months from CPAP titration.
Notably, the patients’ readiness to change was investigated
only in one study (Roecklein et al., 2010) using the SCT and
the TTM Questionnaires adapted for CPAP. Results showed
that motivation improved significantly over time both in the
experimental and the educational control groups, and that
baseline levels of readiness to change were negatively associated
with CPAP use (h/night) at 3-month follow-up.
Potential side effects associated with the use of the CPAP
were also explored by Roecklein et al. (2010), but no between-
group differences were found across time points in both the
motivational intervention and the educational control.
No significant between-group differences were also observed
in the emotional state, daily activities, and social relationships
of the participants in one study (Rudilla et al., 2021). Moreover,
satisfaction with the therapy and the therapist did not appear
to be related to CPAP adherence in another contribution (Olsen
et al., 2012).
DISCUSSION
To our knowledge, this is the first scoping review of the literature
aimed to explore the characteristics and impact of motivational
interventions to promote adherence to CPAP therapy in patients
with OSAS, commonly operationalized as increased daily hours
of CPAP usage.
Results from 9 out of the 11 included studies showed
that motivational interventions were more effective than usual
care and/or educational programs in increasing adherence to
CPAP. However, significant between-group differences favoring
motivational interventions were mostly observed in the short
term, and results were not always maintained over time.
Moreover, adherence declined over time in both the motivational
and control groups in six studies (Roecklein et al., 2010; Olsen
et al., 2012; Aloia et al., 2013; Lai et al., 2014; Lo Bue et al., 2014;
Bakker et al., 2016).
This outcome variability may to some extent be explained
by the characteristics of the intervention, as some contributions
reported on the effect of only one encounter, some of them had
follow-up periods shorter than 3 months, and the treatment was
delivered in different ways (i.e., in-person meetings or remote
interactions; individual or group format).
Still, positive outcomes were observed even in brief
motivational encounters of only 2min (Pengo et al., 2018),
and more than one encounter with a patient seems to increase
the likelihood of an effect.
It should also be considered that aspects such as different
types of healthcare professionals delivering the treatment, and
their training and experience in the use of motivational strategies
may have influenced the magnitude of the treatment, even if this
cannot be shown in this review. Six out of 11 studies (Olsen
et al., 2012; Aloia et al., 2013; Lai et al., 2014; Bakker et al., 2016;
Jean-Louis et al., 2017; Rudilla et al., 2021) reported on how
practitioners were trained, but only two of them (Lai et al., 2014;
Bakker et al., 2016) assessed the treatment fidelity.
Most of the contributions also lack adequate details on the
training of professionals, the contents of the interventions, and
the theoretical models on which they were based.
Motivational interventions are of proven efficacy in improving
adherence to treatment in patients suffering from various
chronic conditions (Burke et al., 2003; Van Nes and Sawatzky,
2010; Maissi et al., 2011; Pietrabissa et al., 2012, 2015, 2017;
Bonde et al., 2014; Soderlund, 2018)—but for the development
of advanced intervention protocols, studies should include
a more comprehensive description and assessment of the
communicational strategies employed in the intervention. In
fact, evidence exists for the correlation between poor compliance
and health care providers’ lack of communication skills. Often,
patients deliberately ignore professionals’ recommendations,
even when change is needed, but this paradoxical behavior
cannot be overcome with rational explanations. Therefore,
mastering communication abilities in the medical setting is
essential to promote low-cost interventions with a positive
cost/benefit ratio.
Since motivational interventions largely depend on “listening”
to the patients and accommodating their ambivalence and
resistance to change—rather than “telling” and educating—the
use of respectful, and compassionate communication may play
a crucial role during the process of ending risk behaviors and/or
adopting positive health behaviors in the clinical context.
In all the selected studies, the motivational strategies
employed in the interventions were largely aimed to address
treatment expectations and ambivalence toward the use of the
CPAP, to define goals, and increase patients’ confidence in their
ability to make enduring behavioral change.
However, a relevant consideration is that only a few
contributions targeted the interventions on the individuals’ initial
level of readiness and confidence to change, thus preventing from
drawing valid conclusions over their outcomes.
Well-established theories of change (Prochaska and
DiClemente, 1983; Miller and Rollnick, 1991) postulates
that patients who are less motivated are expected to be more
responsive to an intervention focused on increasing and
maintaining motivation to change and that lower levels of self-
efficacy reflect the number of previous failed attempts to make
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a change. Moreover, studies show that how patients with OSAS
experience their first month of CPAP therapy may influence their
long-term adherence to the device (Budhiraja et al., 2007; Collen
et al., 2009; Perger et al., 2019).
In the selected contributions, participants were all first-time
CPAP users. It is, therefore, reasonable to believe that the
patients did not fall in the “resistant to change” category—for
which motivational approaches are proven to be most effective.
Accordingly, the only record that assessed the individuals’
readiness to change over time (Roecklein et al., 2010) revealed a
negative association between self-reported motivation to change
and actual use of the CPAP in patients with OSAS. The reduced
superiority of the motivational interventions in increasing
adherence to CPAP among naïve uses might, therefore, also
depend on the patients’ level of motivation. These findings
support the assumption that motivational intervention might
even be counterproductive for highly motivated individuals
(Resnicow and McMaster, 2012). Behavioral change is a complex
phenomenon with multiple determinants that also includes
psychological, motivational, and socio-environmental aspects.
Therefore, assessing the individuals’ adherence to a treatment
regimen also means considering their level of problem awareness
(reasons for change), willingness to change, and perceived ability
to do so (Ceccarini et al., 2015). Subjective measures of adherence
had relatively little representation in the reviewed studies. Yet,
self-report indices of motivation to change do not necessarily
equate to actual change in response to treatment, and they should
be recognized as the patient’s intent at that moment to change
rather than a predictor for any real change in behavior.
Findings from this review also reveal that research testing
the impact of motivational interventions on adherence to CPAP
use among people suffering from OSAS is only recent—as
selected studies were published between 2010 and 2021. Further
studies need to be re-examined by including both objective and
subjective measures of adherence, and longer follow-up periods
that make sure the absence of any dissonance between the
patients’ intention to change and their current status.
Strengths and Limitations
The results of the present scoping review should be interpreted
with the following limitations in mind. First, the search of
electronic databases was limited to trials published in the
English language, and this may have led to the exclusion of
relevant records. Second, there are limitations inherent in the
decision not to include the gray literature, which may have
further impacted the selection of studies and results. Third,
this review investigated treatment components in isolation. As
more trials are published, it may be useful to explore whether
different effects are obtaining by combining treatment strategies,
rather than investigating components in isolation. Fourth,
inconsistent operationalizations and considerable variability in
measures of adherence to treatment, the short-term assessment
of outcomes, and the need for well-trained providers of
motivational interventions were identified as major barriers to
research progress in this area. As a result—despite the strengths
of its well-defined methodology, careful selection of participants,
extensive measures of psychological profile, and outcomes—
this review has limited ability to project the likelihood of
any adherence to CPAP being maintained over time following
motivational interventions.
Future Research and Practical Directions
Although motivational interventions are strongly recommended
in clinical settings (Lim et al., 2019) to facilitate health behavior
change in patients with pulmonary diseases (Minassian and
Doran, 2020), the present findings suggest that several aspects
may impact the intervention efficacy. More research providing a
detailed description of motivational strategies and testing of their
association with positive treatment outcomes is therefore needed.
It would make adherence assessment more straightforward and
increase knowledge on effective mechanisms of change.
Future research may also wish to apply both direct and
indirect measures of adherence and to examine whether the
duration of motivational intervention and frequency of sessions
are associated with treatment effects. Moreover, qualitative
investigations into the type of information or strategy patients
with OSAS find most meaningful may aid in optimizing the
content of the interventions.
Motivational interventions appear to be a useful strategy and
that can easily be broadly disseminated, but more longitudinal
study should test their longer-term effects.
Research also shows that motivational interventions can
effectively be provided digitally to patients with OSAS using
CPAP (Hu et al., 2021), with proven advantages and reduced
costs (Appel et al., 2011; Bus et al., 2018). Further investigations
should focus on the use of the different format of delivering
motivational interventions including the use of new technologies,
or the provision of motivational interventions in group settings
(Velasquez et al., 2006; Channon et al., 2007; Tucker et al.,
2017)—as the group format requires specific competence and
additional tasks, and the motivational strategies are far more
complex to operate than in individual sessions (Major and
Palmer, 2001; Britt et al., 2004; Pietrabissa, 2018). This further
supports the need for studies assessing treatment fidelity, and
that also carefully describe the training offered to providers and
the processes of supervision of motivational sessions (Lim et al.,
2019). The feasibility of implementing MI in the clinical setting
also warrants attention to the patients’ perceived social support
and quality of family relationships, as the interventionsmay differ
depending on the level of involvement of significant others in the
process of change.
CONCLUSION
This scoping review leads to the conclusion that motivational
strategies outperform traditional advice-giving in increasing
adherence to CPAP use in patients with OSAS. However, a
proper evaluation of the individuals’ motivation to change and
the provision of the corresponding motivational strategy in a
clinical setting deserve further attention. Future trials providing
more detailed information on the mechanisms of behavioral
changes would help optimizing the effectiveness of motivational
interventions in adults with OSAS. The cost-effectiveness of
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motivational intervention—alone or in combination with other
interventions—might be a worthwhile endeavor to pursue.
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